BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12973854)

  • 1. Extraocular retinoblastoma: a 13-year experience.
    Antoneli CB; Steinhorst F; de Cássia Braga Ribeiro K; Novaes PE; Chojniak MM; Arias V; de Camargo B
    Cancer; 2003 Sep; 98(6):1292-8. PubMed ID: 12973854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement.
    Antoneli CB; Ribeiro KB; Rodriguez-Galindo C; Soares FA; Arias VA; Novaes PE; Chojniak MM; Malogolowkin M
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):700-4. PubMed ID: 17921851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma in children older than 5 years of age.
    de Aguirre Neto JC; Antoneli CB; Ribeiro KB; Castilho MS; Novaes PE; Chojniak MM; Arias V
    Pediatr Blood Cancer; 2007 Mar; 48(3):292-5. PubMed ID: 16847922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
    Varan A; Kiratli H; Aydın B; Tarlan B; Poyraz CB; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2012 Sep; 29(6):529-37. PubMed ID: 22759219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of overt extraocular retinoblastoma.
    Chantada G; Fandiño A; Casak S; Manzitti J; Raslawski E; Schvartzman E
    Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trilateral retinoblastoma.
    Antoneli CB; Ribeiro Kde C; Sakamoto LH; Chojniak MM; Novaes PE; Arias VE
    Pediatr Blood Cancer; 2007 Mar; 48(3):306-10. PubMed ID: 16572402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
    Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
    Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC
    J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
    Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.
    Taçyildiz N; Yavuz G; Unal E; Gündüz K; Günalp I; Ekinci C
    Pediatr Hematol Oncol; 2003 Sep; 20(6):473-6. PubMed ID: 14631622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic retinoblastoma clinical features, treatment, and prognosis.
    Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
    Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
    J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations and treatment of retinoblastoma in Korea.
    Chung SE; Sa HS; Koo HH; Yoo KH; Sung KW; Ham DI
    Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.